GSK’s ViiV healthcare unit is countering rival HIV drugmaker Gilead’s recent global access moves with its own pledge to make at least 2 million doses of its long-acting pre-exposure prophylaxis (Pr | ...
DNA submitted by users to the genealogy company 23andMe will remain private for now, with CEO Anne Wojcicki saying she no ...
The once-hot Silicon Valley startup has seen its stock’s value decline 99% and is struggling to survive. That has put the ...
TelevisaUnivision CEO WadeDavis will hand the reins of the Spanish-language media giant to Daniel Alegre, the Activision Blizzard and Google alum who joins the company on Thursday. The transition ...
In a move that surprised some and seemed only a matter of time to others, Wade Davis is out as CEO and Daniel Alegre is taking over the Spanish-language media empire. The announcement of the ex ...
In a December 2023 interview with Reuters, GSK CEO Emma Walmsley said that she expects Arexvy to hit blockbuster status. The company took a big step toward this goal in June 2024, when the FDA signed ...
GSK, one of the world's largest vaccine manufacturers, under CEO Emma Walmsley has focussed on vaccines and infectious diseases as a strategy to boost sales and counter patent expiries and ...
GSK has demonstrated robust sales growth, with a 13% increase to GBP 7.9 billion and a core operating profit up by 21% to GBP 2.5 billion, as noted by CEO Emma Walmsley in the latest earnings call.
GSK has demonstrated robust sales growth, with a 13% increase to GBP 7.9 billion and a core operating profit up by 21% to GBP 2.5 billion, as noted by CEO Emma Walmsley in the latest earnings call.
Len Friedland, MD, Vice President of Scientific Affairs and Public Health, GSK, said: “We are excited to share data on the co‑administration of our RSV and shingles vaccines. Adult immunization offers ...
Ford CEO Jim Farley and CFO John Lawler were visiting China in early 2023 when the pair decided to take Changan Automobile's electric SUV for a spin, per the Journal. The Chinese state-owned ...